These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26061031)

  • 21. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients.
    Cai W; Xie Q; An B; Wang H; Zhou X; Zhao G; Guo Q; Gu R; Bao S
    J Clin Virol; 2010 May; 48(1):22-6. PubMed ID: 20233672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy.
    Huang YW; Takahashi S; Tsuge M; Chen CL; Wang TC; Abe H; Hu JT; Chen DS; Yang SS; Chayama K; Kao JH
    Antivir Ther; 2015; 20(4):369-75. PubMed ID: 24739420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.
    Wang HJ; Jiang YF; Wang XR; Zhang ML; Gao PJ
    World J Gastroenterol; 2016 May; 22(18):4529-37. PubMed ID: 27182162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.
    Lee MH; Lee DM; Kim SS; Cheong JY; Cho SW
    J Med Virol; 2011 Jul; 83(7):1178-86. PubMed ID: 21567421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
    Hou FQ; Song LW; Yuan Q; Fang LL; Ge SX; Zhang J; Sheng JF; Xie DY; Shang J; Wu SH; Sun YT; Wei SF; Wang MR; Wan MB; Jia JD; Luo GH; Tang H; Li SC; Niu JQ; Zhou WD; Sun L; Xia NS; Wang GQ
    Theranostics; 2015; 5(3):218-26. PubMed ID: 25553110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of serum total cholesterol with pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.
    Xun Z; Lin JP; Liu C; Huang JL; Shen Y; Xu SY; Wu WN; Ou QS
    Antivir Ther; 2019; 24(2):85-93. PubMed ID: 30520414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
    Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
    Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    Liu X; Shen Z; Zhang H; Liang J; Lin H
    J Interferon Cytokine Res; 2016 Jun; 36(6):367-73. PubMed ID: 26840345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.
    Chen J; Wang Y; Wu XJ; Li J; Hou FQ; Wang GQ
    World J Gastroenterol; 2010 Dec; 16(48):6145-50. PubMed ID: 21182232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dynamic changes of Th1/Th2 type cytokines in peripheral blood of patients with hepatitis B e antigen-positive chronic hepatitis B treated with telbivudine].
    Zhang L; Zhang DZ; Chen M; He H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):175-9. PubMed ID: 19335978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
    Gu Y; Lian Y; Gu L; Chen L; Li X; Zhou L; Huang Y; Wang J; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):216. PubMed ID: 30832595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of HBV-specific CD8
    Wang D; Fu B; Shen X; Guo C; Liu Y; Zhang J; Sun R; Ye Y; Li J; Tian Z; Wei H
    Signal Transduct Target Ther; 2021 Nov; 6(1):376. PubMed ID: 34737296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional response of USP18 predicts treatment outcomes of interferon-alpha in HBeAg-positive chronic hepatitis B patientsefere.
    Liu W; Liang H; Wang S; Wu C; Liu Y; Liu Y; Zhang M; Xiong L; Zhong Z; Chen Y; Mao Q; Ge S; Xia N
    J Viral Hepat; 2019 Sep; 26(9):1050-1058. PubMed ID: 31074081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment.
    Diao H; He J; Zheng Q; Chen J; Cui G; Wei Y; Ye P; Kohanawa M; Li L
    Immunol Lett; 2014 Jul; 160(1):65-71. PubMed ID: 24718278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B.
    Sprengers D; Stoop JN; Binda RS; Kusters JG; Haagmans BL; Carotenuto P; Artsen A; van der Molen RG; Janssen HL
    Antivir Ther; 2007; 12(7):1087-96. PubMed ID: 18018767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.